1672-2809
2012 Issue 2
Introduction and International Experience of Unlicensed and Off-label Drug Uses
HU Ruo-bi;XU-Chun-min;ZHAO Zhi-gang
HU Ruo-bi;XU-Chun-min;ZHAO Zhi-gang
..............page:6-10
..............page:44-46
Analysis the Status and Significance of Medication Guidance Based on the Comprehesion of Patients
FEI si-si;ZHANG Guo-bing;ZHANG Mei-hua;LU Xiao-yang;HANG Han-qiang;LI Jun
FEI si-si;ZHANG Guo-bing;ZHANG Mei-hua;LU Xiao-yang;HANG Han-qiang;LI Jun
..............page:18-20
Drug Interactions of Antihypertensive Drug and Safety Concerns
GUO Shao-jie;ZHAO Xiu-li
GUO Shao-jie;ZHAO Xiu-li
..............page:26-31
..............page:40-43
The Research Progress on the Compatible Stability of Hemostatic and Other Common Medicines
DU Guang;ZHANG Cheng-liang
DU Guang;ZHANG Cheng-liang
..............page:36-39
KAP Investigation on Knowledge ofDrug Safety among Parents of Hospitalized Children
DAI Zhi-ling;CUI Lan;LIANG Guang-qing
DAI Zhi-ling;CUI Lan;LIANG Guang-qing
..............page:12-16
Implications of International Pharmacovigilance on Risk Management of Drugs in China
XU Xiang yang;MAO Rui;REN Xian
XU Xiang yang;MAO Rui;REN Xian
..............page:32-35,39
xuan ze tiao zhan ze ren
ying ying qiu
ying ying qiu
..............page:47
Hpspital Calls forLarge Medicine Package
CHEN Qian;LIU Xuan;DU Guang
CHEN Qian;LIU Xuan;DU Guang
..............page:21-25